DoW Peer Reviewed Cancer, Idea Award
Funds untested, high-risk basic cancer research ideas, explicitly excluding incremental advances or a model swapped from one cancer to another.
Some of the most useful cancer research starts as an idea nobody has tested yet, with no guarantee it goes anywhere, and most funding mechanisms are not built to back that kind of uncertainty.
This one is. It funds innovative, untested, high-risk concepts, theories, paradigms, and basic cancer research, on the argument that advancing knowledge in cancer research, patient care and treatment matter…
Innovative, untested, high-risk basic cancer research advancing knowledge relevant to cancer treatment and patient care in the Military Health System. Incremental advances, the next logical step from existing work, and switching a model system from one cancer to another are explicitly excluded. Preliminary data is not required but a strong scientific rationale is. Includes a new FY26 Early Career Investigator Option.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up